Question 1

What is Hanmi Pharm?

Accepted Answer

Hanmi Pharm is a Company.

Question 2

How often does Hanmi Pharm appear in global news?

Accepted Answer

Tracked across 4 news events drawn from 30 articles.

Question 3

When was Hanmi Pharm first tracked by Ergen?

Accepted Answer

First tracked on May 08, 2026.

Question 4

When was Hanmi Pharm last mentioned in news?

Accepted Answer

Last active on Aug 24, 2026.

Question 5

What is Hanmi Pharm's current news sentiment?

Accepted Answer

Aggregate sentiment score: 58 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Hanmi Pharm in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 4 events.

Question 7

What is the most recent event involving Hanmi Pharm?

Accepted Answer

Hanmi licenses sonefpeglutide to Lilly (Jun 01, 2026, 11 articles).

Question 8

How did the "Hanmi licenses sonefpeglutide to Lilly" event impact Hanmi Pharm?

Accepted Answer

Hanmi Pharm. Co., Ltd. entered into a licensing agreement with Eli Lilly and Company for sonefpeglutide, receiving an upfront payment of USD 75 million and potential milestone payments up to USD 1.185 billion, plus royalties. This significantly boosts its financial outlook and validates its LAPSCOVERY technology.

Question 9

How did the "Hanmi acquires Aptose Biosciences" event impact Hanmi Pharm?

Accepted Answer

Hanmi Pharm, through its subsidiary North American Cobalt Inc., successfully acquired Aptose Biosciences, expanding its oncology pipeline.

Question 10

How did the "Hanmi Pharm Genentech Obesity Licensing Deal" event impact Hanmi Pharm?

Accepted Answer

Hanmi is the licensor, receiving USD 190 million upfront and up to USD 2.3 billion in total deal value. This validates its R&D capabilities and provides substantial financial upside.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.